ID: 206	RANK: 36	SCORE: 21.074011
<DOC>
<DOCNO>
WSJ910520-0118
</DOCNO>
<DOCID>
910520-0118.
</DOCID>
<HL>
   Who's News:
   Eli Lilly &amp; Co. Realigns
   Management as Lange
   Nears Retirement Date
</HL>
<DATE>
05/20/91
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B3
</SO>
<CO>
   LLY WNEWS
</CO>
<MS>
CONSUMER NON-CYCLICAL (NCY)
</MS>
<IN>
DRUG MANUFACTURERS (DRG)
</IN>
<NS>
PERSONNEL ANNOUNCEMENTS, PROMOTIONS, APPOINTMENTS (PER)
</NS>
<RE>
INDIANA (IND)
</RE>
<LP>
   INDIANAPOLIS -- Eli Lilly &amp; Co. announced several
management changes related to the planned June 30 retirement
of E. Walter Lange, 59-year-old group vice president of
marketing, planning and development for the company's
flagship pharmaceutical division.
   Sidney A. Taurel, 42 years old and currently president of
the company's Eli Lilly International Corp. unit, was named
executive vice president of the parent's pharmaceutical
division, responsible for worldwide marketing, planning and
development.
</LP>
<TEXT>
   Succeeding Mr. Taurel as the international unit's
president is Ronald A. Matricaria, 49, currently president of
the parent's Medical Devices &amp; Diagnostics unit.
   Both Mr. Taurel and Mr. Matricaria will report to Eugene
L. Step, who is a Lilly executive vice president and
president of the pharmaceutical division.
   Mr. Matricaria's post as president of the devices and
diagnostics operation will be assumed by Ronald W. Dollens,
44, who is currently the division's vice president, and head
of the division's Advanced Cardiovascular Systems unit.
</TEXT>
</DOC>
